Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients

被引:79
作者
Kusagaya, Hideki [1 ]
Nakamura, Yutaro [1 ]
Kono, Masato [1 ]
Kaida, Yusuke [1 ]
Kuroishi, Shigeki [1 ]
Enomoto, Noriyuki [1 ]
Fujisawa, Tomoyuki [1 ,2 ]
Koshimizu, Naoki [1 ]
Yokomura, Koshi [1 ]
Inui, Naoki [1 ,3 ]
Suda, Takafumi [1 ]
Colby, Thomas V. [4 ]
Chida, Kingo [1 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4313192, Japan
[2] Hamamatsu Univ Sch Med, Dept Lab Med, Hamamatsu, Shizuoka 4313192, Japan
[3] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka 4313192, Japan
[4] Mayo Clin Arizona, Dept Lab Med Pathol, Scottsdale, AZ USA
关键词
Idiopathic interstitial lung disease; Pleural fibrosis; Fibroelastosis; Pleuroparenchymal fibroelastosis; ANTI-FIBROTIC AGENT; PIRFENIDONE; SERUM;
D O I
10.1186/1471-2466-12-72
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
100201 [内科学];
摘要
Background: Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a recently reported group of disorders characterized by fibrotic thickening of the pleural and subpleural parenchyma predominantly in the upper lobes. We report five Japanese cases fulfilling the criteria of IPPFE and address whether it should be considered a separate clinicopathologic entity. And this study was an attempt to identify features in common between IPPFE and previously described idiopathic upper lobe fibrosis (IPUF), allowing IPPFE to be considered as a distinct entity in our Japanese series. Methods: Five consecutive cases of idiopathic interstitial lung disease confirmed as IPPFE by surgical lung biopsy were studied. Results: There were four males and one female, aged 70 +/- 2.76 yr. No associated disorder or presumed cause was found in any case. Lung function tests found a restrictive ventilatory defect (4/5) and/or impairment of DLco (4/5). Chest X-ray showed marked apical pleural thickening in all cases. Computed tomography of the chest in all cases mainly showed intense pleural thickening and volume loss associated with evidence of fibrosis, predominantly in the upper lobes. In all cases in this study, markedly thickened visceral pleura and prominent subpleural fibrosis characterized by both elastic tissue and dense collagen were clearly shown. All cases were alive at the last follow-up, 17.6 +/- 13.59 months after diagnosis; however, all had deteriorated both clinically and radiologically. Conclusions: IPPFE deserves to be defined as a separate, original clinicopathologic entity owing to its uniformity and IPPFE has some features in common with previously described idiopathic upper lobe fibrosis (IPUF). Our limited experience with a cohort of 5 subjects suggests that IPPFE can be rapidly progressive.
引用
收藏
页数:7
相关论文
共 19 条
[1]
Amitani R., 1992, Kokyu, V11, P693
[2]
[Anonymous], 1966, Br Med J, V1, P345
[3]
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis [J].
Azuma, A ;
Nukiwa, T ;
Tsuboi, E ;
Suga, M ;
Abe, S ;
Nakata, K ;
Taguchi, Y ;
Nagai, S ;
Itoh, H ;
Ohi, M ;
Sato, A ;
Kudoh, S ;
Raghu, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (09) :1040-1047
[4]
Pirfenidone: Anti-fibrotic agent with a potential therapeutic role in the management of transplantation patients [J].
Dosanjh, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 536 (03) :219-222
[5]
Pirfenidone: A novel anti-fibrotic agent and progressive chronic allograft rejection [J].
Dosanjh, A ;
Ikonen, T ;
Wan, B ;
Morris, RE .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2002, 15 (05) :433-437
[6]
European Respiratory Society, 2002, Am J Respir Crit Care Med, V165, P277, DOI [10.1164/ajrccm.165.2.ats01, DOI 10.1164/AJRCCM.165.2.ATS01]
[7]
Idiopathic pleuroparenchymal fibroelastosis - Description of a novel clinicopathologic entity [J].
Frankel, SK ;
Cool, CD ;
Lynch, DA ;
Brown, KK .
CHEST, 2004, 126 (06) :2007-2013
[8]
Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS [J].
Greene, KE ;
Wright, JR ;
Steinberg, KP ;
Ruzinski, JT ;
Caldwell, E ;
Wong, WB ;
Hull, W ;
Whitsett, JA ;
Akino, T ;
Kuroki, Y ;
Nagae, H ;
Hudson, LD ;
Martin, TR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (06) :1843-1850
[9]
Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis [J].
Greene, KE ;
King, TE ;
Kuroki, Y ;
Bucher-Bartelson, B ;
Hunninghake, GW ;
Newman, LS ;
Nagae, H ;
Mason, RJ .
EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (03) :439-446
[10]
Kobayashi Y, 1999, Nihon Kokyuki Gakkai Zasshi, V37, P812